HK1085927A1 - The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes - Google Patents
The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetesInfo
- Publication number
- HK1085927A1 HK1085927A1 HK06106013.4A HK06106013A HK1085927A1 HK 1085927 A1 HK1085927 A1 HK 1085927A1 HK 06106013 A HK06106013 A HK 06106013A HK 1085927 A1 HK1085927 A1 HK 1085927A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- lupin conglutin
- foods
- diabetes
- medicament
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000237A ITMI20030237A1 (it) | 2003-02-11 | 2003-02-11 | Uso della conglutina di lupino per il trattamento del |
PCT/EP2004/001111 WO2004071521A1 (fr) | 2003-02-11 | 2004-02-06 | Utilisation de conglutine de lupin aux fins du traitement du diabete non insulino-dependant |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1085927A1 true HK1085927A1 (en) | 2006-09-08 |
Family
ID=32866063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06106013.4A HK1085927A1 (en) | 2003-02-11 | 2006-05-25 | The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes |
Country Status (21)
Country | Link |
---|---|
US (1) | US7323441B2 (fr) |
EP (1) | EP1605957B1 (fr) |
JP (2) | JP2006517212A (fr) |
KR (2) | KR20110033312A (fr) |
CN (1) | CN1747739B (fr) |
AT (1) | ATE391510T1 (fr) |
AU (1) | AU2004212297B2 (fr) |
CA (1) | CA2515607C (fr) |
CY (1) | CY1108138T1 (fr) |
DE (1) | DE602004012984T2 (fr) |
DK (1) | DK1605957T3 (fr) |
ES (1) | ES2303937T3 (fr) |
HK (1) | HK1085927A1 (fr) |
IL (1) | IL170200A (fr) |
IT (1) | ITMI20030237A1 (fr) |
NO (1) | NO333224B1 (fr) |
PL (1) | PL214193B1 (fr) |
PT (1) | PT1605957E (fr) |
RU (1) | RU2339393C2 (fr) |
SI (1) | SI1605957T1 (fr) |
WO (1) | WO2004071521A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
WO2009144278A2 (fr) | 2008-05-30 | 2009-12-03 | Fondazione Centro San Raffaele Del Monte Tabor | Utilisations de conglutine-γ |
US9724664B2 (en) | 2009-03-27 | 2017-08-08 | Bend Research, Inc. | Spray-drying process |
WO2012031133A2 (fr) | 2010-09-03 | 2012-03-08 | Bench Research, Inc. | Appareil de séchage par atomisation et procédés d'utilisation de cet appareil |
PT2611529T (pt) | 2010-09-03 | 2019-05-09 | Bend Res Inc | Método de secagem por pulverização |
EP2618924A1 (fr) | 2010-09-24 | 2013-07-31 | Bend Research, Inc. | Procédé et appareil de séchage par pulvérisation à température élevée |
AU2011315525B2 (en) * | 2010-10-12 | 2016-05-12 | Consumo Em Verde - Biotecnologia Das Plantas, S.A. | Antimicrobial protein |
BR112016030807B1 (pt) * | 2014-06-30 | 2022-03-03 | Prolupin Gmbh | Emulsão com proteína de tremoço, produto substituto de leite, e, método para a produção de uma emulsão com proteína de tremoço |
PT3212169T (pt) | 2014-10-31 | 2021-05-06 | Bend Res Inc | Processo para formar domínios ativos dispersos numa matriz |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
JPH08127538A (ja) * | 1994-10-31 | 1996-05-21 | Masakiyo Takahashi | 糖尿病治療薬 |
JPH0967252A (ja) * | 1995-09-05 | 1997-03-11 | Zenkoku Royal Jelly Kosei Torihiki Kiyougikai | ローヤルゼリーに含まれるトランス−10−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤 |
ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
-
2003
- 2003-02-11 IT IT000237A patent/ITMI20030237A1/it unknown
-
2004
- 2004-02-06 ES ES04708771T patent/ES2303937T3/es not_active Expired - Lifetime
- 2004-02-06 DE DE602004012984T patent/DE602004012984T2/de not_active Expired - Lifetime
- 2004-02-06 PL PL377578A patent/PL214193B1/pl unknown
- 2004-02-06 WO PCT/EP2004/001111 patent/WO2004071521A1/fr active IP Right Grant
- 2004-02-06 US US10/545,103 patent/US7323441B2/en not_active Expired - Lifetime
- 2004-02-06 KR KR1020117005984A patent/KR20110033312A/ko not_active Application Discontinuation
- 2004-02-06 DK DK04708771T patent/DK1605957T3/da active
- 2004-02-06 AT AT04708771T patent/ATE391510T1/de active
- 2004-02-06 RU RU2005125411/15A patent/RU2339393C2/ru not_active IP Right Cessation
- 2004-02-06 PT PT04708771T patent/PT1605957E/pt unknown
- 2004-02-06 CN CN2004800039114A patent/CN1747739B/zh not_active Expired - Fee Related
- 2004-02-06 JP JP2006501760A patent/JP2006517212A/ja not_active Withdrawn
- 2004-02-06 SI SI200430714T patent/SI1605957T1/sl unknown
- 2004-02-06 EP EP04708771A patent/EP1605957B1/fr not_active Expired - Lifetime
- 2004-02-06 AU AU2004212297A patent/AU2004212297B2/en not_active Ceased
- 2004-02-06 CA CA2515607A patent/CA2515607C/fr not_active Expired - Fee Related
- 2004-02-06 KR KR1020057014390A patent/KR101084434B1/ko active IP Right Grant
-
2005
- 2005-08-10 IL IL170200A patent/IL170200A/en active IP Right Grant
- 2005-08-10 NO NO20053788A patent/NO333224B1/no not_active IP Right Cessation
-
2006
- 2006-05-25 HK HK06106013.4A patent/HK1085927A1/xx not_active IP Right Cessation
-
2008
- 2008-06-12 CY CY20081100628T patent/CY1108138T1/el unknown
-
2012
- 2012-04-26 JP JP2012100564A patent/JP5504301B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1085927A1 (en) | The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes | |
WO2001028356A3 (fr) | Complement alimentaire destine a augmenter la masse maigre et la resistance de celle-ci | |
ZA200501559B (en) | Probiotics for gut neuromuscular functions | |
WO2004052295A3 (fr) | Compositions et methodes de supplementation nutritionnelle | |
IL135335A0 (en) | Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids | |
IL172916A0 (en) | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance | |
WO2005123108A3 (fr) | Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue | |
MXPA02011476A (es) | Fuente de triptofano de plantas y usos para el mismo. | |
BR0308713A (pt) | Co-esférula de dha e alecrim, e métodos de uso | |
JP2017057147A (ja) | ニンニク等、低塩分濃度の味噌、及びビタミンb1を含有する組成物 | |
TW200513197A (en) | Amino acid supplementation for a healthy microbiota ecosystem | |
WO2001091769A3 (fr) | Compositions et methodes permettant d'accroitre des effets therapeutiques | |
WO2002089741A3 (fr) | Compositions et methodes permettant d'ameliorer l'administration de medicament | |
MXPA06002648A (es) | Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades medidas por cox-2. | |
PT1768682E (pt) | Produto de origem vegetal compreendendo proantocianidinas e seu processo de preparação | |
HK1075654A1 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
AU2003290031A1 (en) | Method of improvement of blood circulation | |
WO2001091766A3 (fr) | Compositions et procedes destines a traiter les incommodites de la main et du poignet | |
WO2001091771A3 (fr) | Compositions et methodes de traitement de l'incommodite au niveau du dos et des jambes | |
WO2006127759A3 (fr) | Composition de supplement antioxydant et procede d'utilisation | |
JP2017043593A (ja) | 黒ニンニク及びビタミンb1を含有する組成物 | |
NZ512402A (en) | Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale | |
TH87926A (th) | โภชนาการสำหรับผู้ป่วยอ้วนเกิน | |
LT2001072A (lt) | Maisto papildas | |
TH87926B (th) | โภชนาการสำหรับผู้ป่วยอ้วนเกิน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200204 |